FDA Inspection 1251812 — Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H.

Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. — FEI 3008853092

The FDA completed an inspection of Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. on Aug 12, 2021 in Tornesch. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tornesch (Germany)

Additional Details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.